SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F16C77A781C2BAA3471697E5A9FB82D8442A8AFF0E7405D73DD6F3F30D584A32FC7F54D5A2EB77F12353705284EBFA17>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F16C77A781C2BAA3471697E5A9FB82D8442A8AFF0E7405D73DD6F3F30D584A32FC7F54D5A2EB77F12353705284EBFA17
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F16C77A781C2BAA3471697E5A9FB82D8442A8AFF0E7405D73DD6F3F30D584A32FC7F54D5A2EB77F12353705284EBFA17
http://www.w3.org/2000/01/rdf-schema#comment
"BIRC6 targeting inhibited the growth of enzalutamide-resistant castration-resistant prostate cancer models and may represent a new option for clinical treatment of advanced enzalutamide-resistant prostate cancer"
xsd:string
http://purl.uniprot.org/uniprot/#_D2238745087226F8E725845484808391CE053F1FF10E7018F48B13E308459BAD133B7F4FBD8121FD283A8B8A43EAD0B9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F16C77A781C2BAA3471697E5A9FB82D8442A8AFF0E7405D73DD6F3F30D584A32FC7F54D5A2EB77F12353705284EBFA17
http://purl.uniprot.org/uniprot/Q9H8B7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F16C77A781C2BAA3471697E5A9FB82D8442A8AFF0E7405D73DD6F3F30D584A32FC7F54D5A2EB77F12353705284EBFA17
http://purl.uniprot.org/uniprot/#_Q9H8B7-mappedCitation-27663589
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F16C77A781C2BAA3471697E5A9FB82D8442A8AFF0E7405D73DD6F3F30D584A32FC7F54D5A2EB77F12353705284EBFA17